Emergent BioSolutions Inc.
EBS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $51 | -$12 | $68 | -$31 |
| Dep. & Amort. | $23 | $24 | $25 | $26 |
| Deferred Tax | -$10 | -$14 | $19 | -$0 |
| Stock-Based Comp. | $5 | $5 | $2 | $0 |
| Change in WC | -$81 | $96 | -$119 | -$85 |
| Other Non-Cash | $10 | $9 | -$6 | $11 |
| Operating Cash Flow | -$2 | $106 | -$11 | -$80 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$3 | -$4 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $20 | $63 | $30 |
| Investing Cash Flow | -$3 | $17 | $60 | $29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $1 |
| Stock Repurch. | -$9 | -$7 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | -$16 | -$6 | -$0 | $1 |
| Forex Effect | -$0 | $1 | -$1 | $0 |
| Net Chg. in Cash | -$22 | $118 | $47 | -$51 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $271 | $153 | $106 | $156 |
| End Cash | $249 | $271 | $153 | $106 |
| Free Cash Flow | -$6 | $104 | -$15 | -$82 |